| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.88B | 18.21B | 17.99B | 11.71B | 18.93B | 17.61B |
| Gross Profit | 6.50B | 10.44B | 4.60B | 50.00M | 2.43B | 3.90B |
| EBITDA | 2.28B | 1.56B | 4.45B | -773.00M | 2.07B | 4.96B |
| Net Income | 1.73B | 1.18B | 3.27B | -752.00M | 1.36B | 3.78B |
Balance Sheet | ||||||
| Total Assets | 406.16B | 417.20B | 390.83B | 372.41B | 334.22B | 387.30B |
| Cash, Cash Equivalents and Short-Term Investments | 7.34B | 46.40B | 26.72B | 92.10B | 103.08B | 121.36B |
| Total Debt | 6.37B | 6.43B | 6.36B | 6.12B | 6.63B | 6.63B |
| Total Liabilities | 395.95B | 406.30B | 382.56B | 365.52B | 329.12B | 367.03B |
| Stockholders Equity | 10.21B | 10.91B | 8.27B | 6.89B | 5.10B | 20.27B |
Cash Flow | ||||||
| Free Cash Flow | 243.00M | -167.00M | -2.01B | -2.07B | 3.61B | -217.00M |
| Operating Cash Flow | 243.00M | -167.00M | -2.01B | -2.07B | 3.61B | -217.00M |
| Investing Cash Flow | -5.42B | -4.01B | 821.00M | -3.33B | -11.65B | -3.58B |
| Financing Cash Flow | 8.24B | 7.88B | 3.62B | 5.43B | 8.77B | 4.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $3.68B | 3.39 | 11.42% | 2.91% | 17.32% | -0.37% | |
76 Outperform | $12.13B | 10.08 | 20.32% | 0.74% | 3.96% | 18.81% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $4.41B | 25.62 | 9.56% | 1.54% | 5.03% | -12.76% | |
65 Neutral | $7.46B | -4.35 | -3.73% | 2.98% | -20.54% | -652.89% | |
62 Neutral | $6.89B | -9.86 | 16.79% | 3.93% | 8.45% | 21.80% | |
54 Neutral | $3.59B | -1.13 | -1.07% | ― | -16.15% | -133.67% |